| Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge M Bellan, D Soddu, PE Balbo, A Baricich, P Zeppegno, GC Avanzi, ... JAMA network open 4 (1), e2036142-e2036142, 2021 | 520 | 2021 |
| The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma DJ Pinato, R Sharma, E Allara, C Yen, T Arizumi, K Kubota, D Bettinger, ... Journal of hepatology 66 (2), 338-346, 2017 | 382 | 2017 |
| Hyperglycemia-induced thrombin formation in diabetes: the possible role of oxidative stress A Ceriello, R Giacomello, G Stel, E Motz, C Taboga, L Tonutti, M Pirisi, ... Diabetes 44 (8), 924-928, 1995 | 306 | 1995 |
| Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival G Bellone, C Smirne, FA Mauri, E Tonel, A Carbone, A Buffolino, ... Cancer Immunology, Immunotherapy 55, 684-698, 2006 | 294 | 2006 |
| Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases C Colletta, C Smirne, C Fabris, P Toniutto, R Rapetti, R Minisini, M Pirisi Hepatology 42 (4), 838-845, 2005 | 279 | 2005 |
| Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study M Pirisi, C Avellini, C Fabris, C Scott, P Bardus, G Soardo, CA Beltrami, ... Journal of cancer research and clinical oncology 124, 397-400, 1998 | 259 | 1998 |
| IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC C Fabris, E Falleti, A Cussigh, D Bitetto, E Fontanini, S Bignulin, S Cmet, ... Journal of hepatology 54 (4), 716-722, 2011 | 247 | 2011 |
| SAFE biopsy: a validated method for large‐scale staging of liver fibrosis in chronic hepatitis C G Sebastiani, P Halfon, L Castera, S Pol, DL Thomas, A Mangia, ... Hepatology 49 (6), 1821-1827, 2009 | 238 | 2009 |
| Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C D Bitetto, C Fabris, E Fornasiere, C Pipan, E Fumolo, A Cussigh, ... Transplant International 24 (1), 43-50, 2011 | 198 | 2011 |
| Clinical portrait of the SARS-CoV-2 epidemic in European patients with cancer DJ Pinato, A Zambelli, J Aguilar-Company, M Bower, CCT Sng, R Salazar, ... Cancer discovery 10 (10), 1465-1474, 2020 | 188 | 2020 |
| Complementary role of vitamin D deficiency and the interleukin‐28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C D Bitetto, G Fattovich, C Fabris, E Ceriani, E Falleti, E Fornasiere, ... Hepatology 53 (4), 1118-1126, 2011 | 185 | 2011 |
| Post-meal coagulation activation in diabetes mellitus: the effect of acarbose A Ceriello, C Taboga, L Tonutti, R Giacomello, L Stel, E Motz, M Pirisi Diabetologia 39, 469-473, 1996 | 172 | 1996 |
| The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non‐invasive fibrosis biomarkers: an international study of 2411 cases G Sebastiani, L Castera, P Halfon, S Pol, A Mangia, V Di Marco, M Pirisi, ... Alimentary pharmacology & therapeutics 34 (10), 1202-1216, 2011 | 151 | 2011 |
| Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients M Bellan, G Patti, E Hayden, D Azzolina, M Pirisi, A Acquaviva, ... Scientific reports 10 (1), 20731, 2020 | 144 | 2020 |
| PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence E Falleti, C Fabris, S Cmet, A Cussigh, D Bitetto, E Fontanini, E Fornasiere, ... Liver International 31 (8), 1137-1143, 2011 | 141 | 2011 |
| Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 M Bellan, A Baricich, F Patrucco, P Zeppegno, C Gramaglia, PE Balbo, ... Scientific reports 11 (1), 22666, 2021 | 140 | 2021 |
| Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L‐PLUS 2) M Peck‐Radosavljevic, K Simon, A Iacobellis, T Hassanein, Z Kayali, ... Hepatology 70 (4), 1336-1348, 2019 | 139 | 2019 |
| B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) S Bruzzì, S Sutti, G Giudici, ME Burlone, NN Ramavath, A Toscani, ... Free Radical Biology and Medicine 124, 249-259, 2018 | 131 | 2018 |
| Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis E Falleti, D Bitetto, C Fabris, A Cussigh, E Fontanini, E Fornasiere, ... World Journal of Gastroenterology: WJG 16 (24), 3016, 2010 | 127 | 2010 |
| Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma: a response‐based approach G Han, S Berhane, H Toyoda, D Bettinger, O Elshaarawy, AWH Chan, ... Hepatology 72 (1), 198-212, 2020 | 122 | 2020 |
Andrea MagriPost-Doctoral Scientist, University of Oxfordndm.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
